Transforming data from genome-scale assays into knowledge of affected molecular functions and pathways is a key challenge in biomedical research. Using vocabularies of functional terms and databases annotating genes with these terms, pathway enrichment methods can identify terms enriched in a gene list. With data that can refer to intergenic regions, however, one must first connect the regions to the terms, which are usually annotated only to genes. To make these connections, existing pathway enrichment approaches apply unwarranted assumptions such as annotating non-coding regions with the terms from adjacent genes. We developed a computational method that instead links genomic regions to annotations using data on long-range chromatin interactions. Our method, Biological Enrichment of Hidden Sequence Targets (BEHST), finds Gene Ontology (GO) terms enriched in genomic regions more precisely and accurately than existing methods. We demonstrate BEHST's ability to retrieve more pertinent and less ambiguous GO terms associated with results of in vivo mouse enhancer screens or enhancer RNA assays for multiple tissue types. BEHST will accelerate the discovery of affected pathways mediated through long-range interactions that explain non-coding hits in genome-wide association study (GWAS) or genome editing screens. BEHST is free software with a command-line interface for Linux or macOS and a web interface (http://behst.hoffmanlab.org/).
Introduction
High-throughput sequencing enables classes of experiments that produce results in the form of genomic regions. Each experiment identifies particular regions like enhancers, binding sites, open chromatin, or transcripts. We often want to summarize the results of these experiments not as regions, but in understandable terms such as especially affected biological processes or molecular functions. When these regions map neatly to individual genes we can use many of the existing gene set enrichment analysis (GSEA) or pathway enrichment analysis methods [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11] . Most of these methods take a gene list from the experiment, tally functional terms (such as Gene Ontology (GO) [12] terms) previously annotated to the genes, and statistically analyze terms with significant enrichment.
Far fewer tools perform pathway enrichment analysis on arbitrary genomic regions without requiring a gene list. The key problem is that, while genes have comprehensive functional term annotations, other genomic regions generally do not. This necessitates somehow connecting nongenic regions to the annotations on genes. GREAT [13] approaches this problem by defining a regulatory domain for each gene that stretches up to either its nearest neighbors on either side or 1 Mbp, whichever is closest. This assumes inherently that non-coding regions relate most strongly to the nearest genes in one dimension. This assumption may prove reasonable for short distances. As the distance from a non-coding region increases, however, it becomes less likely that it interacts directly with the nearest gene. ChIP-Enrich [14] instead uses ENCODE ChIP-seq peak data sets [15] to link genomic regions to a regulated gene, and then uses a logistic regression approach to estimate the probability of each genomic region to be associated to a particular gene set [14] . TAD Pathways [16] selects genome-wide association study (GWAS) signals for a specific human trait or disease, then finds their topologically associating domains (TADs), and finally selects the genes associated to the boundaries of these TADs.
Several assays directly measure which regions of the genome interact, not just along a chromosome, but in three dimensions. These assays include chromosome conformation capture (3C) [17] and Hi-C [18, 19] . Multiple studies show how long-range chromatin interactions between non-coding regions and distal genes prove critical for understanding the phenotypic effects of genetic variants in these regions [20] . For example, non-coding single nucleotide polymorphisms (SNPs) at the FTO locus drive obesity through interactions with the distal gene IRX3 [21, 22] . As another example, an enhancer at the mouse Lmbr1 locus drives expression of Shh necessary for normal limb development [23] . Mutations in this enhancer can result in preaxial polydactyly, a congenital limb malformation [23, 24] . Additionally, a SNP at the HERC2 locus causes changes in human pigmentation through a long-range chromatin loop with the pigment gene OCA2 [25] . Long-range interactions with the PLCB4 promoter identify it as a potential driver of prostate cancer [26] .
We introduce a new method, Biological Enrichment of Hidden Sequence Targets (BEHST), to use long-range chromatin interaction information for better genomic set enrichment analysis. BEHST incorporates experimental evidence of these interactions from Hi-C datasets [27] . These datasets include chromatin loops that bring linearly distal regions up to hundreds of kilobases away within spatial proximity.
Results
BEHST takes advantage of chromatin loops to precisely associate genes to genomic regions, and then generates an enriched list of functional annotations related to those genes. More precisely, BEHST reads a query dataset of genomic regions, and intersects them with chromatin interactions. BEHST identifies gene cis-regulatory regions on the other side of the chromatin loop. BEHST then uses g:Profiler [7] to identify enriched functional annotations on these genes. These serve as enriched functional annotations for the initial genomic regions linked to these genes via long-range interactions (Methods, Figure 1 Figure 1 : BEHST associates genomic regions with functional annotations on chromatinloop-linked genes. BEHST takes a query region (purple), extends the region (red), and intersects it with long-range chromatin interactions (thin black line). On the other side of the interaction, BEHST extends the region (blue), and identifies the gene cis-regulatory regions (green arrows) within that extension. Finally, BEHST finds enriched annotations (green symbols) from among the identified genes. 
Functional annotations associated with distal enhancers
To examine BEHST's effectiveness, we used it to identify enriched functional annotations in published enhancers. Both VISTA [28] and FANTOM5 [29] identify sets of enhancers active in particular cell or tissue types. Below, we review how well BEHST enrichment on these datasets recapitulated annotations that one would expect to find for those tissue types.
BEHST identifies expected annotations better in VISTA enhancers than in shuffled controls
We applied BEHST to sets of enhancers characterized through transgenic mouse enhancer assays [30] , available in the VISTA Enhancer Browser [28] . Each of these 7 datasets included enhancers active in a particular tissue type. We also compared these VISTA enhancers to two shuffled negative controls. First, we randomly shuffled the enhancers across the whole genome, creating a control input with the same distribution of enhancer size but uncorrelated location. Second, to eliminate effects from moving enhancers between gene-rich and gene-poor regions, we shuffled in a way that preserved distance to the nearest transcription start site (TSS). We did this by identifying the offset between each enhancer and the nearest gene, randomly picking another gene, and moving the enhancer to have the same offset from the new gene (Methods).
BEHST employs two key parameters which control the distance it searches for a chromatin loop from other key regions ( Figure 1 ). The query extension e Q , defines the distance allowed between a query input region and the nearest chromatin loop. The target extension e T , defines the distance allowed between the other side of a chromatin loop and the nearest cis-regulatory region, where a regulatory region is set as a 6 kbp window (5 kbp upstream and 1 kbp downstream, consistent with GREAT [13] ) around the gene's transcription start site (Methods).
To optimize BEHST's query and target extension parameters, we performed a grid search. We ran BEHST on each of the 7 VISTA enhancer datasets with 10 different values for each parameter. This entailed running BEHST on 100 different parameter couples for each dataset, or 700 BEHST executions overall. In each of these 700 cases, we recorded the GO term with the most significant q-value.
In general, we expected to observe more significant enrichment from the unaltered data than from either of the shuffled controls. BEHST identified more significant annotation enrichment for the unmodified VISTA enhancers than shuffled controls in 6 of 7 tissue types ( Table 1 and Figure 3 ). Heart was the only tissue for which the shuffled controls had more significant enrichment than the experimental enhancers. The heart enhancers led BEHST to retrieve several GO terms related to blood, but we expected this association: since many of annotations in the Gene Ontology relate to blood, they are often present in functional enrichment analyses, even after genomic region shuffles.
We used these results to optimize the key extension parameters (Methods). This resulted in optimized values of query extension e Q = 24,100 bp, and target extension e T = 9400 bp. BEHST can retrieve more specific and more relevant GO terms for VISTA enhancers than existing methods
To examine the enriched GO terms found by BEHST, we focused further on the VISTA limb enhancer and nose enhancer datasets. To aid our evaluation, we manually labeled GO terms with independent association with a particular tissue type. We deemed GO terms with biological relevance to the tissue type as expected function (EF), which we analogize to a true positive. We deemed GO terms with biological relevance only to some different tissue type as unexpected function (UF), which we analogize to a false positive. Other GO terms, such as those associated with housekeeping functions and many cell types, we do not deem either as expected or unexpected function. Many of these refer to non-specific nucleic acid metabolism processes associated with numerous gene regulation pathways. Limb enhancers. BEHST retrieved multiple expected function terms associated with limb enhancers ( Table 2 ). The most significant term found was "skeletal system development". BEHST also identified the terms "embryonic limb morphogenesis" and "limb development". All 81 GO terms found by BEHST (q < 0.05) are related to limb, skeleton, embryonic development, or gene regulation.
Unlike in BEHST, limb-related terms did not place highly on GREAT's most significant terms list. GREAT ranks terms related to limb or skeleton in the lowest positions within the significant GO terms retrieved, such as "embryonic limb morphogenesis" ( Table 3 , green rows). GREAT missed the limb-associated term "skeletal system development" found by BEHST. Additionally, GREAT found several unexpected function GO terms unrelated to limb: "cardiovascular system development", "heart development", and "heart morphogenesis" ( Table 3 , red rows).
To examine why GREAT found enriched heart-related terms in a limb enhancer dataset and BEHST did not, we compared the gene lists generated by BEHST and GREAT. ChIP-Enrich does not provide a gene list, so we could not examine its results in the same way. BEHST found 184 genes, while GREAT identified 348 genes. The two sets share 45 genes (Figure 4a-c; p = 2.2 × 10 −46 ; Fisher's exact test). BEHST retrieves fewer genes than GREAT because it uses more stringent gene selection criteria. Consequently, the GO terms found by BEHST contain fewer unexpected functions.
To further investigate why GREAT, but not BEHST, found enrichment for heart-related terms, we examined how each method performed on individual terms. First, we intersected the GREAT and BEHST limb enhancer gene sets with the set of all genes annotated with "heart morphogenesis" (Figure 4a ). The three sets share one common gene, GJA1 BEHST associates 1 other gene, TH, with "heart morphogenesis", but GREAT associates 8. BEHST's additional stringency explains why it did not identify an incorrect association with "heart morphogenesis". We found a similar situation with "heart development", where BEHST identified 6 genes annotated with this term and GREAT identified 24.
We also intersected the GREAT and BEHST limb enhancer gene sets with the set of all genes annotated with "cardiovascular system development" (Figure 4c ). The three sets share one common gene, FOXB1, and neither BEHST nor GREAT identify any of the other 23 genes annotated with "cardiovascular system development".
We also compared BEHST against ChIP-Enrich (Table 4 ). Like BEHST, ChIP-Enrich identified several expected function GO terms using a conventional approach (Table 4, green rows). Unlike BEHST, it also identified many unexpected function GO terms, clearly unrelated to limb, such as "midbrain-hindbrain boundary development" and "brain development" (Table 4 , red rows).
Nose enhancers. As an additional test case, we applied BEHST to the VISTA nose enhancer dataset. As with limb enhancers, BEHST associated nose enhancers with multiple expected function GO terms such as "skeletal system development", "embryonic skeletal system development", and "embryonic skeletal system morphogenesis" ( Table 5 , green rows). By contrast, GREAT found only one relevant term "cerebral cortex neuron differentiation" at a p < 0.05 significance threshold ( Table 6 ). BEHST's retrieved 59 genes for this dataset, while GREAT retrieved 120 genes. Of these genes, BEHST and GREAT share 16, a significant proportion of annotated genes (p = 9.6 × 10 −24 ; Fisher's exact test). The genes GREAT retrieved with the "cerebral cortex differentiation" term included ID4 and ASCL1, a developmental transcription factor involved in q sub-ontology term ID EF/UF term name Green rows: terms that refer to limb or skeleton (expected function, EF). Purple rows: terms that refer generally to embryonic development. White rows: terms not specifically related to any tissue. GO: Gene Ontology. BP: biological process. MF: molecular function. q: g:Profiler g:SCS q-value [7] .
human cerebral cortex neuron differentiation [31] . ChIP-Enrich did find the expected function term "nose development" (Table 7 , green row). BEHST did not identify any genes with the "nose development" term. Finding this term came at the cost of ChIP-Enrich retrieving many unexpected GO terms ( 
BEHST and existing methods retrieve specific and relevant GO terms for FANTOM5 enhancers
To further evaluate the effectiveness of our method, we examined blood enhancers predicted from FANTOM5 cap analysis gene expression (CAGE) data of whole blood [32, 29] . CC GO:0031234 extrinsic to cytoplasmic side of plasma membrane Table 9 : GREAT: FANTOM5 blood. The 31 GO terms found by GREAT for FANTOM5 blood enhancers with p < 0.05. Green rows: terms that refer to blood, specifically (expected functions, EF).
Purple rows: terms that refer generally to blood and immune biology. White rows: terms not specifically related to any tissue. GO: Gene Ontology. BP: biological process. MF: molecular function. CC: cellular component. p: binomial rank p-value.
Blood enhancers. We examined the FANTOM5 blood enhancers with GREAT, BEHST, and ChIP-Enrich. BEHST found multiple expected function GO terms highly specific for blood, including the top terms "regulation of immune system process", "immune system process", and "immune response" (Table 8 , green rows). GREAT generated more GO terms in general, and many of these were expected function terms strictly related to blood ( Table 9 , green rows). ChIP-Enrich even found more expected function GO terms than BEHST and GREAT ( 
BEHST's superior results are robust to different gene set enrichment methods
After identifying target genes, BEHST and GREAT employ different approaches to associate the genes with Gene Ontology terms. GREAT uses a binomial test which explicitly takes into account the variability of gene regulatory domains [13] . BEHST uses g:Profiler [7] , which, in turn, employs the g:SCS (set counts and sizes) method [33] . The g:SCS method computes a multiple testing correction for GO term q-values [34] . It considers statistically significant all terms with corrected q-values in the upper fifth percentile.
BEHST, GREAT, and ChIP-Enrich also use different versions of the Gene Ontology Annotation (GOA) [35] database. Here, BEHST used the GOA database of Ensembl 87 (December 2016) [36] . GREAT used a GOA version prior to February 2015. ChIP-Enrich used a GOA version from Bioconductor 2.13 [37] , released on October 2013.
Outdated Gene Ontology annotations are a major source of differences in pathway enrichment analyses [1] . We wished to eliminate the possibility that these differences in significance tests or annotation databases drove differences in results between BEHST and GREAT. To do this, we took gene lists produced by GREAT, but did not use GREAT's binomial test. Instead, we applied g:Profiler to those gene lists. We could not perform a similar analysis using ChIP-Enrich because it does not produce a gene list as output [38] .
Limb enhancers. First, we ran the hybrid GREAT-g:Profiler analysis on VISTA limb enhancers ( Table 12 ). The hybrid GREAT-g:Profiler analysis found several unexpected function GO terms unrelated to limb, in top positions: "generation of neurons" and "neurogenesis", among others ( Table 12 , red rows). This appeared less specific than the enrichment performed by BEHST on the same dataset ( Table 11 : GREAT-g:Profiler VISTA nose. The 20 GO terms found by g:Profiler using a GREAT gene list for VISTA nose enhancers with p < 0.05. Green rows: terms that strictly refer to nose (expected functions, EF). Purple rows: terms that refer generally to nose biology. Red rows: terms apparently unrelated to nose (unexpected function, UF). GO: Gene Ontology. BP: biological process. CC: cellular component. q: g:Profiler g:SCS q-value [7] .
Nose enhancers. Next, we ran the hybrid GREAT-g:Profiler analysis on VISTA nose enhancers (Table 11 ). Again, the hybrid analysis found several unexpected function GO terms unrelated to nose in top positions, such as "neurogenesis", "generation of neurons", "neuron differentiation", "cerebral cortex neuron differentiation", and many others (Table 11 , red rows). It also found some GO terms generally related to organ development (for example, "animal organ development), but no expected function GO terms strictly related to nose. This appeared far less specific than BEHST's enrichment on the same dataset ( Table 5 ).
q
Unexpected function retrieval rates in enrichment tests
BEHST's main goal is providing genomic set enrichment analysis with fewer unexpected function terms than existing tools such as GREAT and ChIP-Enrich. To avoid the strong assumptions inherent in terms such as true positive and false positive, we instead evaluated these methods in terms of the number of expected function terms (EF) and the number of unexpected function terms (UF). In this study, we limited our analysis to the top 35 GO terms with q < 0.05 or p < 0.05, so the maximum possible values of EF and UF are 35. By analogy to false discovery rate (FDR), we merged EF and UF into a combined measurement called unexpected function rate (UFR), where UFR = UF UF + EF .
UFR ranges from 0 (best) to 1 (worst).
In addition to measuring performance by comparing UF to those terms specifically designated EF, we also compared it against all of the top 35 GO terms retrieved on a dataset with q < 0.05 or p < 0.05. The total number of terms found here also includes broadly relevant terms and non-specific terms, such as those pertaining to gene regulation and housekeeping functions. We call this measurement the total UFR (tUFR), where tUFR = UF total .
Like UFR, tUFR ranges from 0 (best) to 1 (worst Table 12 VISTA nose BEHST 22 3 0 0.00 0.00 Table 5  GREAT 1 0 1 1.00 1.00 Table 6 ChIP-Enrich 35 1 14 0.93 0.40 Table 7 GREAT-g:Profiler 20 0 11 1.00 0.55 Table 11 FANTOM5 blood BEHST 35 15 0 0.00 0.00 Table 8 GREAT 31 13 0 0.00 0.00 Table 9 ChIP-Enrich 35 21 0 0.00 0.00 Table 10 Table 13: Summary of expected function (EF) and unexpected function (UF) terms for each dataset examined. Unexpected function rate UFR = UF/(UF + EF). Total unexpected function rate tUFR = UF/total total: number of terms retrieved with q < 0.05 or p < 0.05, or 35, whichever is smaller.
To quantitatively summarize the individual comparisons of BEHST and other methods, we computed UFR and tUFR for each comparison (Table 13 ). In the VISTA tests, BEHST produced UFR and tUFR lower than all the other methods. In FANTOM5 blood enhancers, no method retrieved a UF term, so all methods tied with UFR of 0.00.
Semantic similarity of enriched terms
To better understand the differences between BEHST and other methods, we generated semantic similarity analyses of enriched GO terms with REVIGO [39] . For each analysis of a GO term list, REVIGO calculated semantic similarity between every pair of terms in the list. Specifically, we used Resnik similarity [40] to estimate how much information content a pair of terms share [41] in the GO Annotation database [42] . REVIGO removed any redundant terms-terms with a very high semantic similarity with another term. Then, REVIGO clustered enriched terms based upon semantic similarity (Methods). BEHST retrieved EF GO terms as single clusters. In VISTA limb enhancers, BEHST retrieved a cluster of EF GO terms represented by "embryonic skeletal system development" and semantically similar terms (Figure 5a ). Thus, BEHST correctly identified a group of similar biological processes, distinct from the rest of the network.
GREAT retrieves UF GO terms as accidental errors in clusters of correct GO terms, or as independent UF clusters. For the limb dataset, GREAT found a set of similar GO terms which contains both EFs and UFs (Figure 5b ). This cluster shows that GREAT retrieved not only GO terms related to limb, but also included unrelated terms, such as "cardiovascular system development".
Discussion
BEHST uses three-dimensional genome organization information instead of adjacency to link arbitrary genomic regions with genes that have annotated GO terms. Using this information, BEHST retrieved more specific and precise GO terms for enriched genomic regions than existing methods. Furthermore, BEHST identified fewer UF GO terms than existing methods, and therefore attained a lower UFR.
We hope to add several extensions to improve BEHST. First, by setting the extension parameters e Q and e T based on the effective resolution of the long-range interaction data (Table 14) , BEHST might provide analyses more tuned to the capabilities of the original experiments. Second, instead of the union of multiple cell types, using chromosome conformation data from only the most relevant cell types could provide more precise enrichment results. Third, adding transcript-centric analysis would allow more use of specific terms annotated to alternative transcripts, where available.
Methods

Datasets
In addition to the query data, BEHST employs three reference datasets:
• Long-range interactions: Hi-C data (GEO accession GSE63525 [27] ) from a union of eight cell types (Table 14; Table 15 );
• Gene annotations: the GENCODE comprehensive gene annotation (version 19 GRCh37.p13 [45] );
• Principal transcript annotations: APPRIS principal isoform annotation (version 2017 01.v20, Species: Human, Assembly Version: GRCh37/hg19, Gene Dataset: Gencode19/Ensembl74 [46] ).
We used human genome assembly GRCh37/hg19 [47] for all analyses. We used enhancers from the VISTA Enhancer Browser [28] , for eye, forebrain, heart, hindbrain, limb, midbrain, and nose. We acquired the FANTOM5 blood enhancer dataset from the Promoter Enhancer Slider Selector Tool (PrESSTo) [29] . 
3D-aware genomic region enrichment
BEHST takes query regions comprising genomic loci of interest and identifies genes and annotation terms associated with these query regions through chromatin looping (Figure 2 ). In short, BEHST expands each query region both upstream and downstream by a query extension e Q , finds long-range interactions with one side within the expanded query region (Figure 2a-c) , and then examines the distal side of these interactions (Figure 2d,i) . At the distal side of a long-rage interaction, BEHST identifies cis-regulatory regions of protein-coding genes (Figure 2e-h) . BEHST uses an upstream and downstream target extension e T to define how far it will search for cis-regulatory regions. Next, BEHST creates a list of all genes in the identified cis-regulatory regions (Figure 2j,k) . Finally, BEHST performs pathway enrichment analysis on this gene list using g:ProfileR [7] (Figure 2l,m) . We describe this procedure in more detail in the following paragraphs. Extended query bounds. BEHST intersects the query regions with the long-range interaction dataset (Figure 2a,b) , and then widens them by the query extension parameter e Q , in both directions. We call these widened regions the extended query bounds.
Long-range interactions. Here, we used a union of chromatin loops Hi-C datasets for the GM12878, HeLa, HMEC, HUVEC, IMR90, K562, KBM7, and NHEK cell types in Hi-C Computational Unbiased Peak Search (HiCCUPS) format [27] . We used the union of all cell types (Table 14c ), rather than one specific cell type, treating the union as a repertoire of potential long-range interactions. This works in all cases, unlike requiring a mapping of a query dataset to a cell-type-specific Hi-C dataset. The appropriate Hi-C dataset to use with many queries is unclear or simply does not exist.
Gene annotation processing. BEHST reads a gene annotation dataset to identify potential target genes. BEHST employs APPRIS [46] to select the principal transcript for each gene. BEHST then uses the principal transcript's identifier to extract transcript features from a gene annotation (Figure 2e-g) . This prevents problems in downstream analysis with multiply counting genes with multiple transcripts.
Extended target bounds. BEHST establishes a basal cis-regulatory region around the principal TSS of each gene (Figure 2h ). To do this, BEHST employs a strand-specific upstream and downstream adjustment (5 kbp upstream and 1 kbp downstream of the TSS). We adapted these values from GREAT [13] .
From the opposite side of any chromatin loops within the extended query bounds, BEHST identifies a widened area for target search called the extended target bounds. For efficiency of implementation, BEHST performs this by actually extending the cis-regulatory regions (Figure 2i ,j), but this is equivalent to extending from the target side of a chromatin loop.
Functional enrichment analysis. BEHST concludes by producing a list of all genes with cis-regulatory regions that overlap with the extended target bounds by ≥1 bp (Figure 2k ). BEHST performs functional enrichment analysis on this gene list using g:ProfileR [7] , with default parameters (Figure 2l ,m).
Parameter optimization
BEHST relies on two extension parameters, the query extension e Q and the target extension e T . To optimize these two parameters and set default values for BEHST, we performed a grid search. We ran BEHST on seven VISTA enhancer datasets (eye, forebrain, heart, hindbrain, midbrain, limb, nose) for ten values of e Q and ten values of e T , from 100 bp to 30,000 bp. We incremented e Q by 3000 bp, and e T by 3100 bp in each step. We chose two different range increments to avoid identical values of the two parameters during the grid search.
For each combination of parameter values and dataset, we identified the q-value of the most significant GO term found by BEHST. We created seven matrices of most significant log 10 (q-values), one for each of the seven VISTA datasets. Each matrix has 10 × 10 cells, each cell containing the most significant log 10 (q-value) for one of 10 values of e Q and one of 10 values of e T .
We created a 10 × 10 summation matrix by summing the values in all seven matrices, cell by cell. From the summation matrix, we selected the cell with the lowest total log 10 (q-value) as parameters to use in all further analyses. This is equivalent to selecting the cell with the lowest mean. This cell corresponds to e Q = 24,100 bp and e T = 9400 bp.
Negative controls
To test correctness of BEHST analyses, we created negative controls by shuffling of lists of query regions with two different procedures.
Total genomic random shuffle. For the total genomic random shuffle procedure, we randomly shuffled the start coordinates of each query region genome-wide, keeping region sizes identical. We performed this shuffle without regard to other genomic elements.
TSS-distance-preserving shuffle. The TSS-distance-preserving shuffle procedure randomly shuffles each query region across the genome, but keeps each query region as near to a TSS as it stood before shuffling. This prevents the bias inherent in a total genomic random shuffle through potentially moving query regions into a gene desert. For each query region, we calculated the distance between the region's start and the nearest TSS of any protein-coding gene. Next, we randomly selected another TSS and moved the query region so that its start has the same distance to the new TSS as the original TSS.
Semantic similarity of enriched terms
We used REVIGO [39] to show the similarity between the GO terms retrieved by BEHST for each query dataset. REVIGO computes semantic similarity between GO terms by considering information content of the terms. REVIGO defines the information content of a GO term as the negative logarithm of the frequency of that term in an annotation database. Here, we used the GO Annotations [35] .
We used REVIGO's implementation of Resnik similarity [40, 48] to estimate how much information content each pair of terms share. Resnik similarity derives from the most informative common ancestor for the two terms, and ranges in the [0, ∞) interval. Two terms with no informative common ancestor have Resnik similarity of 0. Terms with more informative common ancestors have higher Resnik similarities. We used Resnik similarity because it best shows correlation between gene sequence similarities and GO term similarities [49] . Resnik similarity also proves more stable than other similarity measures when used on different version of annotation databases [50, 51] .
We used REVIGO analysis to exemplify differences between BEHST and GREAT on VISTA limb enhancers (Figure 5a,b ). We did not perform this analysis in cases where these differences need little additional exploration. For example, GREAT retrieved only one significant GO term on the VISTA nose enhancers ( Table 5 ). And with the FANTOM5 blood enhancers, tests with BEHST, GREAT, and ChIP-Enrich all led to expected enrichment.
Software availability
BEHST can be used with a web browser (http://behst.hoffmanlab.org).
The BEHST software for Linux and macOS can be downloaded (https://bitbucket.org/ hoffmanlab/behst) under the GNU General Public License version 2 (GPLv2), and can also be installed through the Bioconda [52] package distribution. We have deposited the current version of the software in Zenodo (http://doi.org/10.5281/zenodo.2174744).
